These results suggest that HIF-1α may play a more critical role in the resistance to hyperoxic pretreatment of glioma cells exposed to acute levels of hypoxia than it does in cells maintained under more chronic hypoxic conditions. The gene discussed is HIF1A; the disease is glioma.